4-17486441-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000320.3(QDPR):​c.*690A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.615 in 151,888 control chromosomes in the GnomAD database, including 28,929 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.62 ( 28899 hom., cov: 32)
Exomes 𝑓: 0.47 ( 30 hom. )

Consequence

QDPR
NM_000320.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.25

Publications

11 publications found
Variant links:
Genes affected
QDPR (HGNC:9752): (quinoid dihydropteridine reductase) This gene encodes the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. This enzyme is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems. Mutations in this gene resulting in QDPR deficiency include aberrant splicing, amino acid substitutions, insertions, or premature terminations. Dihydropteridine reductase deficiency presents as atypical phenylketonuria due to insufficient production of biopterin, a cofactor for phenylalanine hydroxylase. [provided by RefSeq, Jul 2008]
QDPR Gene-Disease associations (from GenCC):
  • dihydropteridine reductase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 4-17486441-T-C is Benign according to our data. Variant chr4-17486441-T-C is described in ClinVar as Benign. ClinVar VariationId is 348137.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.686 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000320.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
QDPR
NM_000320.3
MANE Select
c.*690A>G
3_prime_UTR
Exon 7 of 7NP_000311.2
QDPR
NR_156494.2
n.1352A>G
non_coding_transcript_exon
Exon 6 of 6
QDPR
NM_001306140.2
c.*690A>G
3_prime_UTR
Exon 6 of 6NP_001293069.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
QDPR
ENST00000281243.10
TSL:1 MANE Select
c.*690A>G
3_prime_UTR
Exon 7 of 7ENSP00000281243.5
QDPR
ENST00000507439.5
TSL:2
n.*857A>G
non_coding_transcript_exon
Exon 6 of 6ENSP00000423227.1
QDPR
ENST00000706645.1
n.2472A>G
non_coding_transcript_exon
Exon 6 of 6

Frequencies

GnomAD3 genomes
AF:
0.615
AC:
93243
AN:
151558
Hom.:
28864
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.557
Gnomad AMI
AF:
0.652
Gnomad AMR
AF:
0.575
Gnomad ASJ
AF:
0.537
Gnomad EAS
AF:
0.705
Gnomad SAS
AF:
0.637
Gnomad FIN
AF:
0.718
Gnomad MID
AF:
0.673
Gnomad NFE
AF:
0.638
Gnomad OTH
AF:
0.618
GnomAD4 exome
AF:
0.467
AC:
99
AN:
212
Hom.:
30
Cov.:
0
AF XY:
0.469
AC XY:
61
AN XY:
130
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
0.368
AC:
14
AN:
38
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.333
AC:
2
AN:
6
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
81
AN:
162
Other (OTH)
AF:
0.333
AC:
2
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.615
AC:
93325
AN:
151676
Hom.:
28899
Cov.:
32
AF XY:
0.622
AC XY:
46111
AN XY:
74102
show subpopulations
African (AFR)
AF:
0.557
AC:
23037
AN:
41324
American (AMR)
AF:
0.575
AC:
8770
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.537
AC:
1860
AN:
3464
East Asian (EAS)
AF:
0.705
AC:
3610
AN:
5118
South Asian (SAS)
AF:
0.637
AC:
3061
AN:
4806
European-Finnish (FIN)
AF:
0.718
AC:
7571
AN:
10540
Middle Eastern (MID)
AF:
0.686
AC:
199
AN:
290
European-Non Finnish (NFE)
AF:
0.638
AC:
43320
AN:
67852
Other (OTH)
AF:
0.618
AC:
1305
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1837
3675
5512
7350
9187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
770
1540
2310
3080
3850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.628
Hom.:
126602
Bravo
AF:
0.599
Asia WGS
AF:
0.655
AC:
2281
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dihydropteridine reductase deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.12
DANN
Benign
0.44
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1031326; hg19: chr4-17488064; API